GlobeNewsWire
06 Nov 2026, 16:45 UTC · 3h ago
European Commission approves AkzoNobel and Axalta merger of equals
Impact · against what's priced in
The European Commission's conditional approval reduces the execution risk for the AkzoNobel and Axalta merger. While it increases the probability of a closing by early 2027, the realization of synergies remains a future event.
- AKZA+0.60
No priced-in read yet
- In context
Conditional EU approval removes a major regulatory obstacle for the all-stock merger, increasing the likelihood of the deal closing in early 2027.
Read from the article alone
